AnalystBook Research · Company Intelligence

La Rosa Holdings Corp.

LRHCNasdaq

Built from La Rosa Holdings Corp.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score -23.65 — distress zone — historically elevated failure riskWatch
  • Earnings-manipulation signal · Beneish M -10.51 — no flag raisedOK
  • Earnings quality 77/100 — accruals in line with cashOK

Where the revenue comes from

Fiscal 2025, as La Rosa Holdings Corp. reports it. History and quarterly detail are in the app.

  • Real Estate Residential Brokerage Services$66.5M
  • Real Estate Commercial Brokerage Services$694K
  • Coaching Services$444K
  • Property Management$395K
  • Title Settlement and Insurance$298K

Leadership changes

From La Rosa Holdings Corp.'s own filings, the day they're filed.

  • Marc Urbach · Chair of the Compensation Committee · appointmenteff. 2026-10-01
  • Nicholas Adler · Chief Executive Officer · appointmenteff. 2026-10-01
  • Joseph La Rosa · Chief Executive Officer · departureeff. 2026-10-01

Latest filings

  • 8-K · Company announcement2026-10-19
  • 8-K · Company announcement2026-10-01
  • 8-K · Company announcement2026-09-29
  • 8-K · Company announcement2026-09-18
  • 8-K · Company announcement2026-09-16
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about La Rosa Holdings Corp., every answer cited to the official filings🔒
  • The Intelligence Brief — added when La Rosa Holdings Corp.'s brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.